These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
430 related articles for article (PubMed ID: 22286008)
21. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma. Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312 [TBL] [Abstract][Full Text] [Related]
22. The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles. Bao QY; Zhang N; Geng DD; Xue JW; Merritt M; Zhang C; Ding Y Int J Pharm; 2014 Dec; 477(1-2):408-15. PubMed ID: 25455782 [TBL] [Abstract][Full Text] [Related]
23. Multifunctionality of lipid-core micelles for drug delivery and tumour targeting. Sawant RR; Torchilin VP Mol Membr Biol; 2010 Oct; 27(7):232-46. PubMed ID: 20929339 [TBL] [Abstract][Full Text] [Related]
24. In vivo pharmacokinetics, biodistribution and anti-tumor effect of paclitaxel-loaded targeted chitosan-based polymeric micelle. Rezazadeh M; Emami J; Hasanzadeh F; Sadeghi H; Minaiyan M; Mostafavi A; Rostami M; Lavasanifar A Drug Deliv; 2016 Jun; 23(5):1707-17. PubMed ID: 25188785 [TBL] [Abstract][Full Text] [Related]
25. New Folate-Grafted Chitosan Derivative To Improve Delivery of Paclitaxel-Loaded Solid Lipid Nanoparticles for Lung Tumor Therapy by Inhalation. Rosière R; Van Woensel M; Gelbcke M; Mathieu V; Hecq J; Mathivet T; Vermeersch M; Van Antwerpen P; Amighi K; Wauthoz N Mol Pharm; 2018 Mar; 15(3):899-910. PubMed ID: 29341619 [TBL] [Abstract][Full Text] [Related]
26. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039 [TBL] [Abstract][Full Text] [Related]
28. Serum-stable, long-circulating paclitaxel-loaded colloidal carriers decorated with a new amphiphilic PEG derivative. Basile L; Passirani C; Huynh NT; Béjaud J; Benoit JP; Puglisi G; Pignatello R Int J Pharm; 2012 Apr; 426(1-2):231-238. PubMed ID: 22306040 [TBL] [Abstract][Full Text] [Related]
29. Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy. Eloy JO; Petrilli R; Topan JF; Antonio HMR; Barcellos JPA; Chesca DL; Serafini LN; Tiezzi DG; Lee RJ; Marchetti JM Colloids Surf B Biointerfaces; 2016 May; 141():74-82. PubMed ID: 26836480 [TBL] [Abstract][Full Text] [Related]
30. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery. Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618 [TBL] [Abstract][Full Text] [Related]
31. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes. Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917 [TBL] [Abstract][Full Text] [Related]
32. Paclitaxel loaded folic acid targeted nanoparticles of mixed lipid-shell and polymer-core: in vitro and in vivo evaluation. Zhao P; Wang H; Yu M; Liao Z; Wang X; Zhang F; Ji W; Wu B; Han J; Zhang H; Wang H; Chang J; Niu R Eur J Pharm Biopharm; 2012 Jun; 81(2):248-56. PubMed ID: 22446630 [TBL] [Abstract][Full Text] [Related]
33. Preparation, Characterization, and Pharmacokinetic Study of a Novel Long-Acting Targeted Paclitaxel Liposome with Antitumor Activity. Han B; Yang Y; Chen J; Tang H; Sun Y; Zhang Z; Wang Z; Li Y; Li Y; Luan X; Li Q; Ren Z; Zhou X; Cong D; Liu Z; Meng Q; Sun F; Pei J Int J Nanomedicine; 2020; 15():553-571. PubMed ID: 32158208 [TBL] [Abstract][Full Text] [Related]
34. Enhancement of Antitumor Efficacy of Paclitaxel-Loaded PEGylated Liposomes by N,N-Dimethyl Tertiary Amino Moiety in Pancreatic Cancer. Chen Y; Wang L; Luo S; Hu J; Huang X; Li PW; Zhang Y; Wu C; Tian BL Drug Des Devel Ther; 2020; 14():2945-2957. PubMed ID: 32801636 [TBL] [Abstract][Full Text] [Related]
35. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity. Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908 [TBL] [Abstract][Full Text] [Related]
36. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel. Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643 [TBL] [Abstract][Full Text] [Related]
37. Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting. Biswas S; Dodwadkar NS; Sawant RR; Koshkaryev A; Torchilin VP J Drug Target; 2011 Aug; 19(7):552-61. PubMed ID: 21348804 [TBL] [Abstract][Full Text] [Related]
39. Poly(ethylene glycol)-block-poly(ε-caprolactone)-and phospholipid-based stealth nanoparticles with enhanced therapeutic efficacy on murine breast cancer by improved intracellular drug delivery. He X; Li L; Su H; Zhou D; Song H; Wang L; Jiang X Int J Nanomedicine; 2015; 10():1791-804. PubMed ID: 25784805 [TBL] [Abstract][Full Text] [Related]
40. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery. Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]